In this episode we speak with Hari Patel, Senior Director of Product and Portfolio Development, at BioMarin about innovation in rare diseases via gene therapy. Tune in to listen to his journey from Commercial to R&D side of the organization. We cover challenges in the gene therapy landscape and how BioMarin is addressing this high unmet need in multiple ways including working with patient advocacy groups to ensure that patients and their families are present at the right time and right place for clinical trials.Recorded on April 19th, 2019.